InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Tan Kevin, Chief Financial Officer. Insider active across 2 companies, notably Selecta Biosciences INC. In total, 9 disclosures have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €94k. Activity tracked since 2 December 2021. The latest transaction was disclosed on 4 February 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Tan Kevin is Directeur Financier. He has 9 filings in total. Among the 9 recent filings tracked, they cover the period from 2021-12-06 to 2026-02-18, with 13363 in purchases and 80594 in sales, and the most frequent transaction nature is option exercise. The recent activity concerns Solid Biosciences Inc. and Selecta Biosciences INC.